Q3 2025 Holdings
Filed 2025-11-13 | 24 holdings | $437.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $163.5M | 1,658,361 | 37.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $64.5M | 5,376,344 | 14.7% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $60.8M | 1,272,214 | 13.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $29.5M | 3,457,815 | 6.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $27.3M | 22,032,040 | 6.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $17.3M | 349,406 | 3.9% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $15.6M | 7,032,770 | 3.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $13.7M | 1,875,000 | 3.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $12.9M | 2,970,022 | 2.9% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $10.9M | 4,690,431 | 2.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.6M | 505,645 | 1.7% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $5.0M | 2,411,575 | 1.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $4.4M | 2,362,348 | 1.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.4M | 953,834 | 0.3% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $923.8K | 157,646 | 0.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $908.4K | 715,295 | 0.2% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $550.0K | 277,777 | 0.1% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $319.9K | 1,675,000 | 0.1% |
| Bolt Biotherapeutics Inc(BOLT) | COM NEW | 097702203 | $166.5K | 31,305 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $42.7K | 2,928 | 0.0% |
| Senseonics Hldgs Inc(SENS1GBP) | COM | 81727U105 | $18.9K | 43,426 | 0.0% |